World's Best Scientists 2026 revealed!
Steven K. H. Foung

Steven K. H. Foung

D-Index & Metrics

Immunology

D-Index
63
Citations
13333
World Ranking
3042
National Ranking
1426

Steven K. H. Foung publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Steven K. H. Foung sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 180 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Steven K. H. Foung D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Steven K. H. Foung sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Steven K. H. Foung is affiliated with Stanford University in the United States and has a research focus primarily in the field of Medicine. Their work spans several subfields including Hepatology, Radiology, Nuclear Medicine and Imaging, Epidemiology, Infectious Diseases, and Molecular Biology.

The scientist's research topics cover a range of viral studies, notably in Hepatitis C virus research, Monoclonal and Polyclonal Antibodies Research, and Hepatitis B Virus Studies. Additional areas of study include HIV Research and Treatment, Hepatitis Viruses Studies and Epidemiology, and SARS-CoV-2 and COVID-19 Research, including detection and testing.

Frequent publication venues for their research include:

  • Proceedings of the National Academy of Sciences
  • Current Opinion in Virology
  • Science Advances
  • Gastroenterology
  • Journal of Virology

Recent papers authored or co-authored by Steven K. H. Foung include:

  • "An alternate conformation of HCV E2 neutralizing face as an additional vaccine target," 2020, Science Advances
  • "An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development," 2021, Gastroenterology
  • "Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer," 2021, Proceedings of the National Academy of Sciences
  • "Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization," 2020, Journal of Virology
  • "SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution," 2020, Annals of Internal Medicine

Collaborations are a significant aspect of Steven K. H. Foung's work. Frequent co-authors include:

  • Zhen-Yong Keck
  • Thomas R. Fuerst
  • Brian G. Pierce
  • Roy A. Mariuzza
  • Johnathan D. Guest

Best Publications

  • Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent

    Jeff Linnen;John Wages;Zhen-Yong Zhang-Keck;Kirk E. Fry

  • DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2

    Pierre-Yves Lozach;Hugues Lortat-Jacob;Agnès de Lacroix de Lavalette;Isabelle Staropoli

  • The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae

    Jack T. Stapleton;Steven Foung;A. Scott Muerhoff;Jens Bukh;Jens Bukh

  • Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate

    Zhen yong Keck;Jinming Xia;Yong Wang;Wenyan Wang

  • Characterization of Functional Hepatitis C Virus Envelope Glycoproteins

    Anne Op De Beeck;Cécile Voisset;Birke Bartosch;Yann Ciczora

  • V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen.

    Chunghuang Hubert Chan;Kenneth G. Hadlock;Steven K. H. Foung;Shoshana Levy

  • The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

    François Helle;Anne Goffard;Anne Goffard;Virginie Morel;Gilles Duverlie

  • High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

    Marlène Dreux;Marlène Dreux;Thomas Pietschmann;Christelle Granier;Christelle Granier;Cécile Voisset

  • The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.

    Elizabeth R. Quinn;Chunghuang Hubert Chan;Kenneth G. Hadlock;Steven K. H. Foung

  • Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6

    Keigo Machida;Kevin T. H. Cheng;Vicky M.-H. Sung;Alexandra M. Levine

  • Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

    Dorothea Bankwitz;Eike Steinmann;Julia Bitzegeio;Sandra Ciesek

  • Human Monoclonal Antibodies That Inhibit Binding of Hepatitis C Virus E2 Protein to CD81 and Recognize Conserved Conformational Epitopes

    Kenneth G. Hadlock;Robert E. Lanford;Susan Perkins;Judy Rowe

  • CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.

    Jeroen Witteveldt;Matthew J. Evans;Julia Bitzegeio;George Koutsoudakis

  • Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions

    Zhen-Yong Keck;Anne Op De Beeck;Kenneth G. Hadlock;Jinming Xia

  • Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection

    A. M. Arvin;C. M. Koropchak;B. R. G. Williams;F. C. Grumet

  • Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.

    Ania M. Owsianka;Alexander W. Tarr;Zhen-Yong Keck;Ta-Kai Li

  • Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein

    Zhenyong Keck;Wenyan Wang;Yong Wang;Patrick Lau

  • Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

    Rachel Eren;Dorit Landstein;Dov Terkieltaub;Ofer Nussbaum

  • Mapping a Region of Hepatitis C Virus E2 That Is Responsible for Escape from Neutralizing Antibodies and a Core CD81-Binding Region That Does Not Tolerate Neutralization Escape Mutations

    Zhen-Yong Keck;Anasuya Saha;Jinming Xia;Yong Wang

  • Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2

    Zhen-Yong Keck;Ta-Kai Li;Jinming Xia;Birke Bartosch

Frequent Co-Authors

Arvind H. Patel
Arvind H. Patel University of Glasgow
Jonathan K. Ball
Jonathan K. Ball University of Nottingham
Edgar G. Engleman
Edgar G. Engleman Stanford University
Thomas F. Baumert
Thomas F. Baumert University of Strasbourg
Mirjam B. Zeisel
Mirjam B. Zeisel University of Strasbourg
F. Carl Grumet
F. Carl Grumet Stanford University
Brian G. Pierce
Brian G. Pierce University of Maryland, College Park
Jens Bukh
Jens Bukh University of Copenhagen
Félix A. Rey
Félix A. Rey Institut Pasteur
Jean Dubuisson
Jean Dubuisson Institut Pasteur

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology, especially within clinical or research settings, exploring related online degrees can be a strategic step. Many immunology professionals often consider nursing pathways to complement their expertise. Transitioning from an FNP to acute care NP is a popular route for nurses seeking to work in more specialized, hospital-based environments. Programs supporting this transition provide targeted training in acute care, which is essential for managing complex patient cases.

Accelerated educational options are particularly appealing for professionals looking to fast-track their qualifications. The best accelerated nurse practitioner online programs offer flexible schedules and condensed coursework, enabling students to earn their degrees while balancing other responsibilities. Similarly, for those without a nursing background, 12-month accelerated nursing programs online for non nurses present an efficient way to enter the healthcare field without years of prior experience.

Additionally, ABSN programs with high acceptance rates are gaining attention for their accessibility. These programs allow individuals from diverse academic backgrounds to pursue nursing degrees, often with options to specialize further in areas like immunology. Considering these educational pathways alongside immunology studies can open up varied career opportunities in healthcare and research.

Explore these options to find the right fit for your career aspirations:

Best Scientists Citing Steven K. H. Foung

Trending Scientists

Recently Published Articles